✦ LIBER ✦
Development of clinically significant systolic hypertension for the COX-2 selective inhibitor valdecoxib is similar to placebo and conventional NSAIDs in hypertensive patients with chronic arthritis
✍ Scribed by William B. White; Andrew Whelton; Sharon X. Pan; Raymond Cheung
- Book ID
- 116208894
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 65 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0895-7061
No coin nor oath required. For personal study only.